Diagnostic Imaging Clinical Trial
Official title:
Open-label, Non-randomized, Multicenter Positron Emission Tomography (PET) Imaging Study to Evaluate a Single Dose of 250 MBq BAY85-8102 F-18, DPA-714 for Its Diagnostic Potential in Discriminating Patients With Probable Alzheimers Disease From Healthy Volunteers and to Evaluate the Radiation Dosimetry of a Single Dose of 150 MBq BAY858102 F-18, DPA-714 in Healthy Volunteers.
PET (positron emission tomography) imaging with BAY85-8102 F-18, DPA-714 for investigation of neuroinflammation pattern in probable Alzheimers patients versus healthy volunteers and radiation dosimetry in healthy volunteer.
Status | Completed |
Enrollment | 22 |
Est. completion date | October 2010 |
Est. primary completion date | July 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - Able to give fully informed consent in writing - Males or females aged >/= 50 years - No significant disease or drug use - Absence of any sign of dementia/cognitive impairment in neuropsychological examinationsPatients for brain imaging: - Patient and designee capable of giving fully informed consent in writing - Patient fulfils DSM-IV and NINCDS-ADRA criteria for probable Alzheimers disease - Patient has undergone physical and neurological examination, ECG and test of routine hematological and biochemical parameters prior to radiotracer administration Exclusion Criteria:- Pregnancy or lactation - Current unstable medical condition (e.g. unstable angina, myocardial infarction or coronary revascularization in the preceding 12 months, cardiac failure, chronic renal failure, chronic hepatic disease, severe pulmonary disease, blood disorders, poorly controlled diabetes, chronic infection) |
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Bayer |
Finland, Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Discrimination of probable Alzhemimer disease patients from healthy volunteers by BAY85-81 F-18, DPA-714 brain PET imaging as evaluated by different quantification approaches | Day of Study tracer administration | No | |
Secondary | Discrimination of probable Alzhemimer disease patients from healthy volunteers by BAY85-81 F-18, DPA-714 brain PET imaging as evaluated by visual analysis and standard parameters(e.g. Standardized Uptake Values = SUV) | Day of Study tracer administration | No | |
Secondary | Electrocardiogram (ECG) | At least once within 8 days after treatment | Yes | |
Secondary | Blood pressure | At least 2 times within 8 days after treatment | Yes | |
Secondary | Serum protein | At least once within 8 days after treatment | Yes | |
Secondary | Serum creatinine | At least once within 8 days after treatment | Yes | |
Secondary | Serum GOT (Glutamat-Oxalacetate-Transaminase) | At least once within 8 days after treatment | Yes | |
Secondary | Adverse events collection | Continuously and for a maximum of 28 days after end of observation phase | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01415414 -
Observational Study of Ultravist in Patients Requiring CECT
|
N/A | |
Terminated |
NCT00975299 -
Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05036460 -
Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients
|
N/A | |
Recruiting |
NCT05610098 -
Gene Expression Profiles in Spinal Tuberculosis.
|
||
Completed |
NCT00244140 -
Ultravist: Safety and Efficacy in Computed Tomography of Head and Body
|
Phase 3 | |
Completed |
NCT02980081 -
Abdominal Plain X-ray in the Emergency Departement
|
N/A | |
Completed |
NCT01205321 -
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT05823857 -
Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT04859634 -
Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
|
||
Completed |
NCT03125629 -
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
|
Phase 2 | |
Terminated |
NCT03167190 -
Ultrasound-Assisted Lumbar Puncture
|
N/A | |
Completed |
NCT01297088 -
PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.
|
Phase 1 | |
Completed |
NCT01089998 -
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
|
Phase 1 | |
Completed |
NCT00347022 -
A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications
|
Phase 4 | |
Completed |
NCT00876083 -
PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination
|
N/A | |
Completed |
NCT01411449 -
Primovist Post-marketing Surveillance in Japan
|
N/A | |
Completed |
NCT01153607 -
Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00709852 -
Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
|
Phase 3 | |
Terminated |
NCT00659776 -
MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation
|
Phase 2 | |
Recruiting |
NCT05733377 -
Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome
|